Form 4: Voyager Therapeutics COO Robin Swartz Sells Shares
SEC Form 4 Filing
Robin Swartz, COO & CBO of Voyager Therapeutics, sold 3,087 shares of common stock at an average price of $5.09 on January 14, 2025.
Summary
- On January 14, 2025, Robin Swartz, the COO & CBO of Voyager Therapeutics, Inc., sold 3,087 shares of the company's common stock.
- The shares were sold at a weighted average price of $5.09.
- The price range for the sales was between $5.05 and $5.23.
- Following the transaction, Swartz directly owns 109,241 shares of Voyager Therapeutics.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock sale. The sale itself doesn't necessarily indicate a positive or negative outlook.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company executives and their holdings in the company.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, although it is a relatively small transaction.
Key Dates
| Date | Description |
|---|---|
| 01/14/2025 | Date of stock sale transaction |
| 01/15/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.